BioSpace News Archive

United Therapeutics Corporation announced that Dr. Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company’s business during a fireside chat session at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit.

NanoViricides, Inc. a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announced that it has nominated a clinical drug candidate for the treatment of COVID-19, thus further advancing its COVID-19 program closer to human clinical trials.

The Russian Direct Investment Fund, Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd., a global pharmaceutical company headquartered out of India, have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.

Vivera Pharmaceuticals, Inc. is pleased to announce the launch of BIOZONE, an innovative device designed for sanitization in high occupancy settings.

Primary endpoint of viral load change from baseline at day 11 was met for one of three doses; consistent effects of viral reduction seen at earlier time points

Merck, known as MSD outside the United States and Canada, announced that members of management will host a virtual investor event following the European Society for Medical Oncology Virtual Congress 2020 where they will highlight select datasets and give an overview of the company’s broad oncology portfolio on Sept.

HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, announced that HOOKIPA’s management team will participate and present at SVB Leerink’s CybeRx Series: Vaccine Forum, taking place September 23 – 24, 2020:

100 patient blinded, randomized, biomarker-directed Phase 2 study will use neuroimaging technology to study the complex biology of treatment resistant disease

Special Meetings to Be Held on October 29, 2020 Unanimously Recommend Stockholders Vote “For” the Merger and Other Proposals Set Forth in the Definitive Proxy Statement Transaction on Track to Close by End of Fourth Quarter of 2020

NANO-X IMAGING LTD, an innovative medical imaging technology company, issued a statement in response to unusual trading activities that occurred on September 15, 2020.